Accenture: Makes An Investment In 1910 Genetics
Accenture ventures, the venture capital arm of accenture, has invested in 1910 genetics, a biotechnology company focused on drug discovery using a multimodal artificial. Accenture has invested, through accenture ventures, in 1910 genetics, a biotech company advancing small and large molecule drug discovery through an ai platform. October 31, 2024 at 10:55 am edt. Accenture has invested, through accenture ventures, in 1910 genetics, a biotech company advancing small and large molecule drug. Acn) has invested, through accenture ventures, in 1910 genetics (or 1910), a.